Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 3481 to 3486 of 3486 entries
Sorted by: Best Match Show Resources per page
Impact of clinical posting in psychiatry on the attitude towards mental illness in undergraduate final year medical students.

Asian journal of psychiatry

Pal T, Singh S.
PMID: 34990913
Asian J Psychiatr. 2021 Dec 31;69:103001. doi: 10.1016/j.ajp.2021.103001. Epub 2021 Dec 31.

INTRODUCTION: The stigma in psychiatry is pervasive, it is more serious obstacle for treatment initiation. Stigmatization among health professional themselves can result in compromised patient care. The aim of this study is to see the impact of psychiatry clinical...

Cite
Pal T, Singh S. Impact of clinical posting in psychiatry on the attitude towards mental illness in undergraduate final year medical students. Asian J Psychiatr. 2021;69:103001doi: 10.1016/j.ajp.2021.103001.
Pal, T., & Singh, S. (2021). Impact of clinical posting in psychiatry on the attitude towards mental illness in undergraduate final year medical students. Asian journal of psychiatry, 69103001. https://doi.org/10.1016/j.ajp.2021.103001
Pal, Tarun, and Singh, Swati. "Impact of clinical posting in psychiatry on the attitude towards mental illness in undergraduate final year medical students." Asian journal of psychiatry vol. 69 (2021): 103001. doi: https://doi.org/10.1016/j.ajp.2021.103001
Pal T, Singh S. Impact of clinical posting in psychiatry on the attitude towards mental illness in undergraduate final year medical students. Asian J Psychiatr. 2021 Dec 31;69:103001. doi: 10.1016/j.ajp.2021.103001. Epub 2021 Dec 31. PMID: 34990913.
Copy Download .nbib Format: NLM
Human cell transformation by combined lineage conversion and oncogene expression.

Oncogene

Sahu B, Pihlajamaa P, Zhang K, Palin K, Ahonen S, Cervera A, Ristimäki A, Aaltonen LA, Hautaniemi S, Taipale J.
PMID: 34302118
Oncogene. 2021 Sep;40(36):5533-5547. doi: 10.1038/s41388-021-01940-0. Epub 2021 Jul 23.

Cancer is the most complex genetic disease known, with mutations implicated in more than 250 genes. However, it is still elusive which specific mutations found in human patients lead to tumorigenesis. Here we show that a combination of oncogenes...

Cite
Sahu B, Pihlajamaa P, Zhang K, et al. Human cell transformation by combined lineage conversion and oncogene expression. Oncogene. 2021;40(36):5533-5547doi: 10.1038/s41388-021-01940-0.
Sahu, B., Pihlajamaa, P., Zhang, K., Palin, K., Ahonen, S., Cervera, A., Ristimäki, A., Aaltonen, L. A., Hautaniemi, S., & Taipale, J. (2021). Human cell transformation by combined lineage conversion and oncogene expression. Oncogene, 40(36), 5533-5547. https://doi.org/10.1038/s41388-021-01940-0
Sahu, Biswajyoti, et al. "Human cell transformation by combined lineage conversion and oncogene expression." Oncogene vol. 40,36 (2021): 5533-5547. doi: https://doi.org/10.1038/s41388-021-01940-0
Sahu B, Pihlajamaa P, Zhang K, Palin K, Ahonen S, Cervera A, Ristimäki A, Aaltonen LA, Hautaniemi S, Taipale J. Human cell transformation by combined lineage conversion and oncogene expression. Oncogene. 2021 Sep;40(36):5533-5547. doi: 10.1038/s41388-021-01940-0. Epub 2021 Jul 23. PMID: 34302118; PMCID: PMC8429043.
Copy Download .nbib Format: NLM
Cardiovascular outcomes of type 2 diabetic patients treated with DPP‑4 inhibitors versus sulphonylureas as add-on to metformin in clinical practice.

Scientific reports

Bazo-Alvarez JC, Pal K, Pham TM, Nazareth I, Petersen I, Sharma M.
PMID: 34903733
Sci Rep. 2021 Dec 13;11(1):23826. doi: 10.1038/s41598-021-02670-9.

DPP-4 inhibitors (DPP-4i) and sulphonylureas remain the most widely prescribed add-on treatments after metformin. However, there is limited evidence from clinical practice comparing major adverse cardiovascular events (MACE) in patients prescribed these treatments, particularly among those without prior history...

Cite
Bazo-Alvarez JC, Pal K, Pham TM, et al. Cardiovascular outcomes of type 2 diabetic patients treated with DPP‑4 inhibitors versus sulphonylureas as add-on to metformin in clinical practice. Sci Rep. 2021;11(1):23826doi: 10.1038/s41598-021-02670-9.
Bazo-Alvarez, J. C., Pal, K., Pham, T. M., Nazareth, I., Petersen, I., & Sharma, M. (2021). Cardiovascular outcomes of type 2 diabetic patients treated with DPP‑4 inhibitors versus sulphonylureas as add-on to metformin in clinical practice. Scientific reports, 11(1), 23826. https://doi.org/10.1038/s41598-021-02670-9
Bazo-Alvarez, Juan Carlos, et al. "Cardiovascular outcomes of type 2 diabetic patients treated with DPP‑4 inhibitors versus sulphonylureas as add-on to metformin in clinical practice." Scientific reports vol. 11,1 (2021): 23826. doi: https://doi.org/10.1038/s41598-021-02670-9
Bazo-Alvarez JC, Pal K, Pham TM, Nazareth I, Petersen I, Sharma M. Cardiovascular outcomes of type 2 diabetic patients treated with DPP‑4 inhibitors versus sulphonylureas as add-on to metformin in clinical practice. Sci Rep. 2021 Dec 13;11(1):23826. doi: 10.1038/s41598-021-02670-9. PMID: 34903733.
Copy Download .nbib Format: NLM
Pancreatoduodenectomy enlarged to the portal vein and hepatic artery with solely venous axis reconstruction.

Surgical oncology

Garnier J, Bonnet J, Palen A, Turrini O.
PMID: 34992031
Surg Oncol. 2021 Dec 31;40:101703. doi: 10.1016/j.suronc.2021.101703. Epub 2021 Dec 31.

No abstract available.

Cite
Garnier J, Bonnet J, Palen A, et al. Pancreatoduodenectomy enlarged to the portal vein and hepatic artery with solely venous axis reconstruction. Surg Oncol. 2021;40:101703doi: 10.1016/j.suronc.2021.101703.
Garnier, J., Bonnet, J., Palen, A., & Turrini, O. (2021). Pancreatoduodenectomy enlarged to the portal vein and hepatic artery with solely venous axis reconstruction. Surgical oncology, 40101703. https://doi.org/10.1016/j.suronc.2021.101703
Garnier, Jonathan, et al. "Pancreatoduodenectomy enlarged to the portal vein and hepatic artery with solely venous axis reconstruction." Surgical oncology vol. 40 (2021): 101703. doi: https://doi.org/10.1016/j.suronc.2021.101703
Garnier J, Bonnet J, Palen A, Turrini O. Pancreatoduodenectomy enlarged to the portal vein and hepatic artery with solely venous axis reconstruction. Surg Oncol. 2021 Dec 31;40:101703. doi: 10.1016/j.suronc.2021.101703. Epub 2021 Dec 31. PMID: 34992031.
Copy Download .nbib Format: NLM
Molecular targets and therapeutics in chemoresistance of triple-negative breast cancer.

Medical oncology (Northwood, London, England)

Nath A, Mitra S, Mistry T, Pal R, Nasare VD.
PMID: 34812991
Med Oncol. 2021 Nov 23;39(1):14. doi: 10.1007/s12032-021-01610-x.

Triple-negative breast cancer (TNBC) is a specific subtype of breast cancer (BC), which shows immunohistochemically negative expression of hormone receptor i.e., Estrogen receptor and Progesterone receptor along with the absence of Human Epidermal Growth Factor Receptor-2 (HER2/neu). In Indian...

Cite
Nath A, Mitra S, Mistry T, et al. Molecular targets and therapeutics in chemoresistance of triple-negative breast cancer. Med Oncol. 2021;39(1):14doi: 10.1007/s12032-021-01610-x.
Nath, A., Mitra, S., Mistry, T., Pal, R., & Nasare, V. D. (2021). Molecular targets and therapeutics in chemoresistance of triple-negative breast cancer. Medical oncology (Northwood, London, England), 39(1), 14. https://doi.org/10.1007/s12032-021-01610-x
Nath, Arijit, et al. "Molecular targets and therapeutics in chemoresistance of triple-negative breast cancer." Medical oncology (Northwood, London, England) vol. 39,1 (2021): 14. doi: https://doi.org/10.1007/s12032-021-01610-x
Nath A, Mitra S, Mistry T, Pal R, Nasare VD. Molecular targets and therapeutics in chemoresistance of triple-negative breast cancer. Med Oncol. 2021 Nov 23;39(1):14. doi: 10.1007/s12032-021-01610-x. PMID: 34812991.
Copy Download .nbib Format: NLM
Smooth Transition for Advancement to Graduate Education (STAGE) for Underrepresented Groups in the Mathematical Sciences Pilot Project: Broadening Participation through Mentoring.

Eubanks-Turner C, Beaulieu P, Pal N.
UIID-AD: 4799
2018;97-117. doi: 10.1080/10511970.2017.1295409.

The Smooth Transition for Advancement to Graduate Education (STAGE) project was a three-year pilot project designed to mentor undergraduate students primarily from under-represented groups in the mathematical sciences. The STAGE pilot project focused on mentoring students as they transitioned...

Cite
Eubanks-Turner C, Beaulieu P, Pal N. Smooth Transition for Advancement to Graduate Education (STAGE) for Underrepresented Groups in the Mathematical Sciences Pilot Project: Broadening Participation through Mentoring. 2018;97-117doi: 10.1080/10511970.2017.1295409.
Eubanks-Turner, C., Beaulieu, P., & Pal, N. (2018). Smooth Transition for Advancement to Graduate Education (STAGE) for Underrepresented Groups in the Mathematical Sciences Pilot Project: Broadening Participation through Mentoring. 97-117. https://doi.org/10.1080/10511970.2017.1295409
Eubanks-Turner, C, et al. "Smooth Transition for Advancement to Graduate Education (STAGE) for Underrepresented Groups in the Mathematical Sciences Pilot Project: Broadening Participation through Mentoring." vol. (2018): 97-117. doi: https://doi.org/10.1080/10511970.2017.1295409
Eubanks-Turner C, Beaulieu P, Pal N. Smooth Transition for Advancement to Graduate Education (STAGE) for Underrepresented Groups in the Mathematical Sciences Pilot Project: Broadening Participation through Mentoring. 2018;97-117. doi: 10.1080/10511970.2017.1295409. UIID-AD: 4799.
Copy Download .nbib Format: NLM
Showing 3481 to 3486 of 3486 entries